Pre-clinical assessment of chimeric antigen receptor t cell therapy targeting CD19+ B cell malignancy

BACKGROUND: Autologous chimeric antigen receptor (CAR) T cell therapy is a promising therapeutic strategy for treating hematologic malignancies. A spectrum of serious complications caused by CAR-T cells has caught great attention. We developed a novel CAR against CD19 namely UWC19, consisting anti-C...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Ann Transl Med
Egile Nagusiak: Hu, Sheng-I, Ko, Ming-Chin, Dai, Yi-Han, Lin, Hsin-An, Chen, Lih-Chyang, Huang, Kuo-Yang, Pang, Te-Ling, Kuo, Cheng-Yi, Lin, Hsin-Chung
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: AME Publishing Company 2020
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7290534/
https://ncbi.nlm.nih.gov/pubmed/32566611
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2020.02.148
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak